Literature DB >> 15158519

What is the contribution of obesity to the metabolic syndrome?

Scott M Grundy1.   

Abstract

Many prospective studies show that obesity is accompanied by increased risk for cardiovascular disease. Obesity affects metabolism of lipids and glucose, regulation of blood pressure, thrombotic and fibrinolytic processes, and inflammatory reactions. Multiple aberrations exist in each of these systems; obesity acting alone probably is not sufficient to produce full-blown metabolic syndrome. There must be other factors, including genetic and aging factors. It is difficult to sort out all pathogenic factors that link obesity to cardiovascular disease risk. It is worthwhile to investigate individually the components of the obesity-induced metabolic syndrome for their atherogenic potential, because out of that investigation likely will come new targets for clinical or public health intervention to reduce the risk for cardiovascular disease.

Entities:  

Mesh:

Year:  2004        PMID: 15158519     DOI: 10.1016/j.ecl.2004.03.001

Source DB:  PubMed          Journal:  Endocrinol Metab Clin North Am        ISSN: 0889-8529            Impact factor:   4.741


  22 in total

1.  The health implications of sucrose, high-fructose corn syrup, and fructose: what do we really know?

Authors:  James M Rippe
Journal:  J Diabetes Sci Technol       Date:  2010-07-01

2.  Association of metabolic syndrome with reduced central serotonergic activity.

Authors:  Rocio Herrera-Marquez; Jorge Hernandez-Rodriguez; Julio Medina-Serrano; Alfonso Boyzo-Montes de Oca; Gabriel Manjarrez-Gutierrez
Journal:  Metab Brain Dis       Date:  2010-12-22       Impact factor: 3.584

Review 3.  Mediators of sympathetic activation in metabolic syndrome obesity.

Authors:  Nora E Straznicky; Nina Eikelis; Elisabeth A Lambert; Murray D Esler
Journal:  Curr Hypertens Rep       Date:  2008-12       Impact factor: 5.369

Review 4.  Direct effects of leptin and adiponectin on peripheral reproductive tissues: a critical review.

Authors:  Jennifer F Kawwass; Ross Summer; Caleb B Kallen
Journal:  Mol Hum Reprod       Date:  2015-05-11       Impact factor: 4.025

5.  Strain/strain rate imaging of impaired left atrial function in patients with metabolic syndrome.

Authors:  Ning-Ning Fang; Dong-Xin Sui; Jin-Gui Yu; Hui-Ping Gong; Ming Zhong; Yun Zhang; Wei Zhang
Journal:  Hypertens Res       Date:  2015-07-16       Impact factor: 3.872

6.  Insulin and insulin resistance.

Authors:  Gisela Wilcox
Journal:  Clin Biochem Rev       Date:  2005-05

7.  Potential role of interleukin-18 in patients with rheumatoid arthritis-associated carotid intima-media thickness but not insulin resistance.

Authors:  Mehmet Şahin; Yunus Ugan; Şevket Ercan Tunç; Şule Akın; Banu Köroğlu; Ali Kutlucan; Recep Sütçü; Ahmet Yeşildağ; Aysun Kılbaş
Journal:  Eur J Rheumatol       Date:  2014-12-01

8.  Waist circumference is the best anthropometric predictor for insulin resistance in nondiabetic patients with schizophrenia treated with clozapine but not olanzapine.

Authors:  David C Henderson; Xiaoduo Fan; Bikash Sharma; Paul M Copeland; Christina P C Borba; Oliver Freudenreich; Corinne Cather; A Eden Evins; Donald C Goff
Journal:  J Psychiatr Pract       Date:  2009-07       Impact factor: 1.325

Review 9.  The inflammation highway: metabolism accelerates inflammatory traffic in obesity.

Authors:  Amy R Johnson; J Justin Milner; Liza Makowski
Journal:  Immunol Rev       Date:  2012-09       Impact factor: 12.988

Review 10.  Adiposopathy is a more rational treatment target for metabolic disease than obesity alone.

Authors:  Harold Bays; Carlos A Dujovne
Journal:  Curr Atheroscler Rep       Date:  2006-03       Impact factor: 5.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.